2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
| 热门AI工具: |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文讨论生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐: | 热 PeerJ Computer Science|SCI收录,计算机科学多领域广泛收稿 | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | ONCOLOGY REPORTS ONCOL REP (此期刊被最新的JCR期刊SCIE收录) LetPub评分 5.3
58人评分
我要评分
声誉 4.1 影响力 5.3 速度 8.8 | |||||||||||||||||||||
| 期刊ISSN | 1021-335X | 安装APP,查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 1791-2431 | |||||||||||||||||||||
| 2025-2026最新IF (数据来源于网友提供) | 注册或登录后,查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年9月20日:2.874 | |||||||||||||||||||||
| 2025-2026自引率 | 0.0%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF (数据来源于网友提供) | 3.902数据由网友[brightrabbit213]收集提供 | |||||||||||||||||||||
| h-index | 84 | |||||||||||||||||||||
| CiteScore ( 2026年6月最新版) |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://www.spandidos-publications.com/or | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | http://www.spandidos-publications.com/login | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | FXYD5 promotes the growth of glioblastoma by targeting the PI3K/AKT/ACSL4 signaling axis Author: Wang, Bang; Qin, Yong; Cheng, Hang; Zeng, Yibin; Jiang, Lianglei; Hu, Xuebin Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 5, pp. -. DOI: 10.3892/or.2026.9193 Overcoming melanoma drug resistance: Mechanisms and clinical progress of oncolytic viruses combined with immune checkpoint inhibitors (Review) Author: He, Yuan; Lin, Wenxuan; Chen, Haofang; Guan, Yongqi; Guan, Congcong; Zhang, Yanxiang; Pan, Dongsheng Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 5, pp. -. DOI: 10.3892/or.2026.9197 Effect of EZH2 regulation of the JAK2/STAT3 signaling pathway on proliferation and apoptosis in non-small cell lung cancer cells Author: Wu, Shuang; Zhang, Wei Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 5, pp. -. DOI: 10.3892/or.2026.9190 Decoding the metabolic-immune crosstalk: The role of glutamine and ammonium reprogramming in prostate cancer immune evasion (Review) Author: Wang, Peilong; Li, Xiaoran; Ma, Teng; Mi, Jun Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 4, pp. -. DOI: 10.3892/or.2026.9186 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足ONCOLOGY REPORTS的语言要求,还能让ONCOLOGY REPORTS编辑和审稿人得到更好的审稿体验,让稿件最大限度地被ONCOLOGY REPORTS编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(2篇) 论文致谢(4篇) 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | SPANDIDOS PUBL LTD, POB 18179, ATHENS, GREECE, 116 10 | |||||||||||||||||||||
| 出版商 | Spandidos Publications | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | GREECE | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||
| 出版年份 | 1994 | |||||||||||||||||||||
| 年文章数 | 118点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 85.28% | |||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 58.47% | |||||||||||||||||||||
| WOS期刊JCR分区 ( 2025-2026年最新版) | 注册或登录后,查看WOS分区等级 | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:预警等级:中 | |||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1021-335X%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: 平均5.5月 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验: 约54.23% | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在ONCOLOGY REPORTS顺利发表。
快看看作者怎么说吧:服务好评(2篇) 论文致谢(4篇) 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | FXYD5 promotes the growth of glioblastoma by targeting the PI3K/AKT/ACSL4 signaling axis Author: Wang, Bang; Qin, Yong; Cheng, Hang; Zeng, Yibin; Jiang, Lianglei; Hu, Xuebin Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 5, pp. -. DOI: 10.3892/or.2026.9193 PubMed DOI |
| 2. | Overcoming melanoma drug resistance: Mechanisms and clinical progress of oncolytic viruses combined with immune checkpoint inhibitors (Review) Author: He, Yuan; Lin, Wenxuan; Chen, Haofang; Guan, Yongqi; Guan, Congcong; Zhang, Yanxiang; Pan, Dongsheng Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 5, pp. -. DOI: 10.3892/or.2026.9197 PubMed DOI |
| 3. | Effect of EZH2 regulation of the JAK2/STAT3 signaling pathway on proliferation and apoptosis in non-small cell lung cancer cells Author: Wu, Shuang; Zhang, Wei Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 5, pp. -. DOI: 10.3892/or.2026.9190 PubMed DOI |
| 4. | Decoding the metabolic-immune crosstalk: The role of glutamine and ammonium reprogramming in prostate cancer immune evasion (Review) Author: Wang, Peilong; Li, Xiaoran; Ma, Teng; Mi, Jun Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 4, pp. -. DOI: 10.3892/or.2026.9186 PubMed DOI |
| 5. | Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review) Author: Zhang, Yuantao; Shang, Yiyang; Zeng, Hai; Ning, Ruiling; Zhang, Xinran; Ao, Dongxu; Cai, Jun; Ye, Qingqing Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 4, pp. -. DOI: 10.3892/or.2026.9187 PubMed DOI |
| 6. | Genomic instability, postoperative recurrence and therapeutic vulnerabilities in resectable non-small cell lung cancer (Review) Author: Wang, Linlin; Feng, Yong; Liu, Qiang Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 4, pp. -. DOI: 10.3892/or.2026.9188 PubMed DOI |
| 7. | CTGF: The remodeler of the tumor immune microenvironment (Review) Author: Zhao, Ying; Han, Li; Wu, Qingyu; Li, Haiying; Dai, Fuhong Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 4, pp. -. DOI: 10.3892/or.2026.9172 PubMed DOI |
| 8. | Polyphenol-based interventions in breast cancer: Signaling pathways, molecular mechanisms and translational therapeutic strategies (Review) Author: Zeng, Jingjing; Hu, Jinyan; Ma, Zhiyuan; Zhu, Suansuan; Lv, Xiangling; Zhang, Lanhai; Shen, Mimi; Li, Taolang Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 4, pp. -. DOI: 10.3892/or.2026.9176 PubMed DOI |
| 9. | HDAC1 promotes lung adenocarcinoma progression via the nuclear accumulation of β-catenin Author: Xu, Shijie; Chang, Xiaolu; Wu, Xiayu; Wang, Fabao; Xiang, Jing; Lin, Chaoxiang; Zhao, He; Li, Junzhe; Xu, Xianhua Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 4, pp. -. DOI: 10.3892/or.2026.9175 PubMed DOI |
| 10. | OLR1 promotes cell proliferation and invasion while represses apoptosis via regulating histone H3 lysine 18 lactylation-mediated LEMD1 in papillary thyroid cancer Author: Yu, Jiawei; Pang, Rui; Liu, Bo; Chen, Lili; Zhang, Jiewu Journal: ONCOLOGY REPORTS. 2026; Vol. 56, Issue 4, pp. -. DOI: 10.3892/or.2026.9178 PubMed DOI |
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共823条 |
||||||||||||||||
|
|

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室